A focus on a prominent women's health issue: optimising iron stores in pregnancy, dealing with postpartum haemorrhage and minimising transfusion.
| Presenters: | Dr Elske Posma, Head of Obstetrics, Western Health |
|---|---|
| Dr Aggie Kujawa, General Practice Obstetrics Registrar, Leongatha | |
| Dr Cindy Flores, Transfusion Policy and Education Project Officer, Australian Red Cross Blood Service |
17 October 2018 01:30 - 02:30pm - Australia/Sydney
Direct oral anticoagulants (DOACs) are indicated for the prevention of systemic embolism in selected patients with non-valvular atrial fibrillation and for the prevention and /or treatment of venous thromboembolism. Guidance on when and how to reverse DOACs is discussed.
| Presenter: | Dr Simon McRae, Chairman, Australian Haemophilia Centre Directors Organisation, Consultant Haematologist SA Pathology, Royal Adelaide Hospital. |
|---|
12 September 2018 01:30 - 02:30pm - Australia/Sydney
SHOT is the United Kingdom's independent, professionally-led haemovigilance scheme. Since 1996 SHOT has been collecting and analysing anonymised information on adverse events and reactions in blood transfusion from all healthcare organisations that are involved in the transfusion of blood and blood components in the United Kingdom. Where risks and problems are identified, SHOT produces recommendations to improve patient safety.
| Presenter: | Dr Paula Bolton-Maggs, Medical Director, Serious Hazards of Transfusion Scheme NHSBT, UK |
|---|
18 April 2018 01:30 - 02:30pm - Australia/Sydney
Trauma is the leading cause of death worldwide in individual's aged 18-39 with data from the WHO suggesting that worldwide almost 6 million deaths every year are directly attributable to trauma. Despite advances in trauma management, a significant proportion of these deaths are still due to haemorrhage. Death can occur early as a result of uncontrollable haemorrhage; in patients where surgical haemorrhage control is achieved subsequent morbidity and mortality can be attributed to effects of massive haemorrhage and large volume blood product transfusion. This session will provide an update for the Feisty Study - An Australian multi-centre randomised, controlled trial studying the effects of rapid fibrinogen replacement in severely bleeding trauma patients.
| Presenter: | Dr James Winearls, Consultant Intensivist, Gold Coast University Hospital, (Chief Investigator). |
|---|
8 November 2017 01:30pm - 02:30pm - Australia/Adelaide
This session provides an overview of possible clinical errors during a blood transfusion.
| Presenter: | Dr Beveleigh Quested, Transfusion Education Manager, Blood Service. |
|---|
Since 1967, the lives of countless babies have been saved by the pioneering Rh Program - and to date, over three million doses of anti-D have been given to Rh negative women.
The program provides plasma collected from blood donors with anti-D for production of anti-D immunoglobulin for treatment of RhD negative women with babies at risk of haemolytic disease of the fetus and newborn (HDFN).
The following two presentations commemorate 50 years of the Anti-D Program and look at the prevention of Rh HDFN.
| Presenters: | Jessie Wallis, RhD Program Coordinator, South Australia, Australian Red Cross Blood Service. |
|---|---|
| Dr Amanda Thomson, Haematologist/Transfusion Medicine Specialist, Australian Red Cross Blood Service. |
16 August 2017 12:30pm - 01:30pm - Australia/Sydney
The research and development team at the Blood Service conducts leading-edge research to find improved ways to process, store and distribute blood components. This session explores data linkage and provides an update on a data linkage study in maternity.
| Presenter: | Professor David Irving, Director, Research and Development, Blood Service. |
|---|
10 May 2017 01:30pm - 02:30pm - Australia/Sydney
How I get the best out of a platelet transfusion.
| Presenter: | Dr Richard Kaufman, Associate Professor of Pathology, Harvard Medical School and Medical Director of Adult Transfusion Medicine Service, Brigham and Women's Hospital, United States of America. |
|---|
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Meghan Delaney, Associate Professor, Laboratory Medicine, University of Washington and Medical Director, Transfusion and Apheresis Services, Seattle Children's Hospital, United States of America.
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Nancy Dunbar, Associate Professor, The Geisel School of Medicine and Medical Director, Blood Bank, Dartmouth-Hitchcock Medical Centre, New Hampshire, United States of America.
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Lilon Bandler, Associate Professor, Indigenous Health Education Unit, Sydney Medical School, University of Sydney, Australia.
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Emanuele Di Angelantonio, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge and NHSBT, England.
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Meghan Delaney, Associate Professor, Laboratory Medicine, University of Washington and Medical Director, Transfusion and Apheresis Services, Seattle Children's Hospital, United States of America.
Transfusion Update 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Mark Yazer, Professor of Pathology, University of Pittsburgh and member of the Institute for Transfusion Medicine, United States of America.
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr James Winearls, Consultant Intensivist, Gold Coast University Hospital, Australia
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Richard Kaufman, Associate Professor of Pathology, Harvard Medical School and Medical Director of Adult Transfusion Service, Brigham and Women's Hospital, United States of America
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Lacey Johnson, Principal Research Fellow, Australian Red Cross Blood Service
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Mark Fung, Director of Clinical Laboratories, University of Vermont Medical Center and Professor of Pathology and Laboratory Medicine, University of Vermont, United States of America.
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Alan Tinmouth, Assistant Professor, Departments of Benign Hematology and Transfusion Medicine, Ottawa Hospital and the University of Ottawa, Canada.
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Phillip Mondy, Transfusion Medicine Specialist, Australian Red Cross Blood Service, Australia.